APVO
Price
$3.08
Change
-$0.15 (-4.64%)
Updated
Jun 27 closing price
Capitalization
9.93M
IBO
Price
$0.75
Change
-$0.17 (-18.48%)
Updated
Jun 27 closing price
Capitalization
9.09M
Interact to see
Advertisement

APVO vs IBO

Header iconAPVO vs IBO Comparison
Open Charts APVO vs IBOBanner chart's image
Aptevo Therapeutics
Price$3.08
Change-$0.15 (-4.64%)
Volume$308.18K
Capitalization9.93M
Impact BioMedical
Price$0.75
Change-$0.17 (-18.48%)
Volume$2.29M
Capitalization9.09M
APVO vs IBO Comparison Chart in %
Loading...
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APVO vs. IBO commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APVO is a Hold and IBO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (APVO: $3.08 vs. IBO: $0.75)
Brand notoriety: APVO and IBO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APVO: 5% vs. IBO: 15%
Market capitalization -- APVO: $9.93M vs. IBO: $9.09M
APVO [@Biotechnology] is valued at $9.93M. IBO’s [@Biotechnology] market capitalization is $9.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APVO’s FA Score shows that 1 FA rating(s) are green whileIBO’s FA Score has 0 green FA rating(s).

  • APVO’s FA Score: 1 green, 4 red.
  • IBO’s FA Score: 0 green, 5 red.
According to our system of comparison, both APVO and IBO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APVO’s TA Score shows that 3 TA indicator(s) are bullish while IBO’s TA Score has 5 bullish TA indicator(s).

  • APVO’s TA Score: 3 bullish, 3 bearish.
  • IBO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IBO is a better buy in the short-term than APVO.

Price Growth

APVO (@Biotechnology) experienced а -26.14% price change this week, while IBO (@Biotechnology) price change was +107.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APVO($9.93M) has a higher market cap than IBO($9.09M). IBO has higher P/E ratio than APVO: IBO (8.10) vs APVO (0.00). IBO YTD gains are higher at: -48.138 vs. APVO (-96.427). IBO (-22.79M) and APVO (-23.79M) have comparable annual earnings (EBITDA) . APVO has more cash in the bank: 2.14M vs. IBO (1.32M). APVO has less debt than IBO: APVO (4.42M) vs IBO (9.14M). APVO (0) and IBO (0) have equivalent revenues.
APVOIBOAPVO / IBO
Capitalization9.93M9.09M109%
EBITDA-23.79M-22.79M104%
Gain YTD-96.427-48.138200%
P/E Ratio0.008.100%
Revenue00-
Total Cash2.14M1.32M162%
Total Debt4.42M9.14M48%
FUNDAMENTALS RATINGS
APVO vs IBO: Fundamental Ratings
APVO
IBO
OUTLOOK RATING
1..100
9499
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
48
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9864
P/E GROWTH RATING
1..100
5898
SEASONALITY SCORE
1..100
n/a30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APVO's Valuation (11) in the Biotechnology industry is somewhat better than the same rating for IBO (48) in the null industry. This means that APVO’s stock grew somewhat faster than IBO’s over the last 12 months.

APVO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IBO (100) in the null industry. This means that APVO’s stock grew similarly to IBO’s over the last 12 months.

IBO's SMR Rating (99) in the null industry is in the same range as APVO (100) in the Biotechnology industry. This means that IBO’s stock grew similarly to APVO’s over the last 12 months.

IBO's Price Growth Rating (64) in the null industry is somewhat better than the same rating for APVO (98) in the Biotechnology industry. This means that IBO’s stock grew somewhat faster than APVO’s over the last 12 months.

APVO's P/E Growth Rating (58) in the Biotechnology industry is somewhat better than the same rating for IBO (98) in the null industry. This means that APVO’s stock grew somewhat faster than IBO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APVOIBO
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
67%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
6%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
6%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
APVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LUV32.160.64
+2.03%
Southwest Airlines Co
DBI2.460.04
+1.65%
Designer Brands
TCBI78.960.14
+0.18%
Texas Capital Bancshares
CATO2.76-0.01
-0.36%
CATO Corp
APRE1.67-0.08
-4.42%
Aprea Therapeutics

APVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, APVO has been loosely correlated with ENLV. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APVO jumps, then ENLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APVO
1D Price
Change %
APVO100%
-4.64%
ENLV - APVO
36%
Loosely correlated
-0.83%
GNPX - APVO
28%
Poorly correlated
-4.70%
KROS - APVO
28%
Poorly correlated
-0.15%
IBO - APVO
27%
Poorly correlated
-18.26%
IMRX - APVO
26%
Poorly correlated
+10.66%
More

IBO and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBO has been loosely correlated with ITOS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if IBO jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBO
1D Price
Change %
IBO100%
-18.26%
ITOS - IBO
44%
Loosely correlated
-0.70%
BMRN - IBO
42%
Loosely correlated
+1.98%
NCNA - IBO
29%
Poorly correlated
N/A
APVO - IBO
27%
Poorly correlated
-4.64%
ADAG - IBO
24%
Poorly correlated
-1.03%
More